FDA has enormous backlog of manufacturing unit inspections as staffers depart for private sector jobs U.S. health and fitness inspectors remain having difficulties to deal with a massive backlog of pharmaceutical vegetation that went uninspected all through disruptions a result of COVID-19.Providers clinging to pre-pandemic office norms are missing